Mechlorethamine Induced Contact Dermatitis Avoidance Study
Status:
Recruiting
Trial end date:
2020-12-13
Target enrollment:
Participant gender:
Summary
This is a two-arm, open-label study that aims to compare the incidence and severity of the
most common adverse reactions, particularly contact dermatitis, when Valchlor is used alone
or in conjunction with triamcinolone ointment 0.1% in early stage MF subjects (Stage IA and
IB) for a period of 4 months.